Outcomes of conversion surgery after immune checkpoint inhibitor-based combination therapy in initially unresectable hepatocellular carcinoma: A retrospective cohort study. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results